用户名: 密   码:
注册 | 忘记密码?
药品详细

Bentiromide(苯替酪胺 )

化学结构式图
中文名
苯替酪胺
英文名
Bentiromide
分子式
C23H20N2O5
化学名
4-[(2S)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic acid
分子量
Average: 404.4153
Monoisotopic: 404.13722176
CAS号
37106-97-1
ATC分类
V04C 未知
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍

Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada (It was withdrawn in the US in October 1996).

生产厂家
  • Savage laboratories inc div altana inc
封装厂家
参考
Synthesis Reference Not Available
General Reference
  1. Toskes PP: The bentiromide test for pancreatic exocrine insufficiency. Pharmacotherapy. 1984 Mar-Apr;4(2):74-80. Pubmed
剂型
规格
化合物类型
Type small molecule
Classes Not Available
Substructures Not Available
适应症
药理
Indication Used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy.
Pharmacodynamics Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of p-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada.
Mechanism of action Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. By determining the output of unchanged bentiromide in the urine following oral administration, it is possible to determine the sufficiency of pancreatic activity.
Absorption Not Available
Volume of distribution Not Available
Protein binding Not Available
Metabolism
Primarily hepatic. Enzymatic activity capable of hydrolyzing bentiromide has also been found in normal small intestine.
Route of elimination Not Available
Half life Not Available
Clearance Not Available
Toxicity Symptoms of overdose include shortness of breath and troubled breathing.
Affected organisms
  • Humans and other mammals
Pathways Not Available
理化性质
Properties
State solid
Experimental Properties
Property Value Source
melting point 241 °C PhysProp
logP 3.3 Not Available
Predicted Properties
Property Value Source
water solubility 4.12e-03 g/l ALOGPS
logP 2.99 ALOGPS
logP 3.54 ChemAxon
logS -5 ALOGPS
pKa (strongest acidic) 4.16 ChemAxon
pKa (strongest basic) -1.3 ChemAxon
physiological charge -1 ChemAxon
hydrogen acceptor count 5 ChemAxon
hydrogen donor count 4 ChemAxon
polar surface area 115.73 ChemAxon
rotatable bond count 7 ChemAxon
refractivity 112.75 ChemAxon
polarizability 42.16 ChemAxon
药物相互作用
食物相互作用
Not Available

返回 | 收藏